Is obesity caused by an adenovirus?

Expert Review of Anti-Infective Therapy

Volumn 10, Issue 5, 2012, Pages 521-524

  Dhurandhar, Nikhil V ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Ad 36; adipogenesis; adiposity; infectobesity; obesity virus

Indexed keywords

ANTIVIRUS AGENT;

ADENOVIRUS; ADENOVIRUS 2; ADENOVIRUS 31; ADENOVIRUS 36; ADENOVIRUS 37; ADENOVIRUS 5; ADENOVIRUS INFECTION; ADIPOCYTE; CELL PROLIFERATION; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE COURSE; EPIDEMIC; HEALTH PROMOTION; HELICOBACTER INFECTION; HUMAN; INFECTION PREVENTION; LIFESTYLE MODIFICATION; LONGITUDINAL STUDY; NONHUMAN; NUTRITION; OBESITY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PREVALENCE; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH SERVICE; REVIEW; RISK ASSESSMENT; RISK FACTOR; VIRUS STRAIN; WART VIRUS;

ADENOVIRIDAE; ADENOVIRUS INFECTIONS, HUMAN; ADIPOSE TISSUE; ADIPOSITY; ANIMALS; DNA, VIRAL; HUMANS; OBESITY;

EID: 84862577244     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.12.41     Document Type: Review

References (31)

1. Dhurandhar NV. A framework for identification of infections that contribute to human obesity. Lancet Infect. Dis. 11(12), 963-969 (2011).
2. James PT, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Obes. Res. 9(Suppl. 4), 228S-233S (2001).
3. Berrington De Gonzalez A, Hartge P, Cerhan JR et al. Body-mass index and mortality among 1.46 million white adults. N. Engl. J. Med. 363, 2211-2219 (2010).
4. Bray GA, Bellanger T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 29(1), 109-117(2006).
5. McAllister EJ, Dhurandhar NV, Keith SW et al. Ten putative contributors to the obesity epidemic. Crit. Rev. Food Sci. Nutr. 49(10), 868-913 (2009).
6. Dhurandhar NV, Kulkarni P, Ajinkya SM, Sherikar A. Effect of adenovirus infection on adiposity in chicken. Vet. Microbiol. 31(2-3), 101-107 (1992).
7. Dhurandhar NV, Kulkarni PR, Ajinkya SM, Sherikar AA, Atkinson RL. Association of adenovirus infection with human obesity. Obes. Res. 5(5), 464-469 (1997).
8. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew G, Cook ME, Atkinson RL. Transmissibility of adenovirus-induced adiposity in a chicken model. Int. J. Obes. Relat. Metab. Disord. 25(7), 990-996 (2001).
9. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew GF, Cook ME, Atkinson RL. Increased adiposity in animals due to -rfaut human virus. Int. J. Obes. Relat. Metab. Disord. 24(8), 989-996 (2000).
10. Pasarica M, Shin AC, Yu M et al. Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity (Silver Spring.) 14(11), 1905-1913 (2006).
11. Dhurandhar NV, Whigham LD, Abbott DH et al. Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys. J. Nutr. 132(10), 3155-3160 (2002).
12. Whigham LD, Israel BA, Atkinson RL. Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290(1), R190-R194 (2006).
13. So PW, Herlihy AH, Bell JD. Adiposity induced by adenovirus 5 inoculation. Int. J. Obes. (Lond.) 29(6), 603-606 (2005).
14. Sandoval DA, Seeley RJ. Medicine. The microbes made me eat it. Science 328(5975), 179-180 (2010).
15. Wigand R, Gelderblom H, Wadell G. New human adenovirus (candidate adenovirus 36), a novel member of subgroup D. Arch. Virol. 64(3), 225-233 (1980).
16. Krishnapuram R, Dhurandhar EJ, Dubuisson O et al. Template to improve glycemic control without reducing adiposity or dietary fat. Am. J. Physiol. Endocrinol. Metab. 300(5), E779-E789 (2011).
17. Pasarica M, Loiler S, Dhurandhar NV. Acute effect of infection by adipogenic human adenovirus Ad-36. Arch. Virol. 153(11), 2097-2102 (2008).
18. Rathod MA, Rogers PM, Vangipuram SD, McAllister EJ, Dhurandhar NV. Adipogenic cascade can be induced without adipogenic media by a human adenovirus. Obesity (Silver Spring.) 17(4), 657-664 (2009).
19. Pasarica M, Mashtalir N, McAllister EJ et al. Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells. Stem Cells 26(4), 969-978 (2008).
20. Rathod M, Vangipuram SD, Krishnan B, Heydari AR, Holland TC, Dhurandhar NV. Viral mRNA expression but not DNA replication is required for lipogenic effect of human adenovirus Ad-36 in preadipocytes. Int. J. Obes. (Lond.) 31(1), 78-86 (2007).
21. Vangipuram SD, Sheele J, Atkinson RL, Holland TC, Dhurandhar NV. A human adenovirus enhances preadipocyte differentiation. Obes. Res. 12(5), 770-777 (2004).
22. Na HN, Kim H, Nam JH. Novel genes and cellular pathways related to infection with adenovirus-36 as an obesity agent in human mesenchymal stem cells. Int. J. Obes. (Lond.) 36(2), 195-200 (2012).
23. Rogers PM, Fusinski KA, Rathod MA et al. Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene. Int. J. Obes. (Lond.) 32(3), 397-406 (2008).
24. Na HN, Nam JH. Adenovirus 36 as an obesity agent maintains the obesity state by increasing MCP-1 and inducing inflammation. J. Infect. Dis. 205(6), 914-922 (2012).
25. Vangipuram SD, Yu M, Tian J et al. Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int. J. Obes. (Lond.) 31(1), 87-96 (2007).
26. Dhurandhar EJ, Dubuisson O, Mashtalir N, Krishnapuram R, Hegde V, Dhurandhar NV. E4orf1: A novel ligand that improves glucose disposal in cell culture. PLoS ONE 6(8), e23394 (2011).
27. Thomas GCR, Tilkorn D, Keramidaris E, Morrison W, Penington A, Blick T. Effect of human adenovirus-36 in a localized in vivo model of neoadipogenesis. Obesity 16, S74 (2008).
28. Atkinson RL, Dhurandhar NV, Allison DB et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int. J. Obes. (Lond.) 29(3), 281-286 (2005).
29. Trovato GM, Martines GF, Trovato FM et al. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. Dig. Dis. Sci. 57(2), 535-544 (2012).
30. Trovato GM, Martines GF, Garozzo A et al. Ad-36 adipogenic adenovirus in human non-alcoholic fatty liver disease. Liver Int. 30(2), 184-190 (2010).
31. Trovato GM, Castro A, Tonzuso A et al. Human obesity relationship with Ad-36 adenovirus and insulin resistance. Int. J. Obes. (Lond.) 33(12), 1402-1409 (2009).